Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ALHC
ALHC logo

ALHC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Alignment Healthcare Inc (ALHC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
21.860
1 Day change
2.05%
52 Week Range
23.870
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Alignment Healthcare Inc (ALHC) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the stock has shown recent price growth, key indicators such as overbought RSI levels, hedge fund selling, and mixed analyst ratings suggest caution. The lack of recent news or significant positive catalysts further supports a hold recommendation.

Technical Analysis

The MACD histogram is positive at 0.745, indicating bullish momentum, but it is contracting. RSI is at 83.836, signaling an overbought condition. Moving averages are converging, which suggests indecision in price direction. Key resistance levels are at $21.748 and $23.48, with support at $18.944 and $16.14.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate bullish sentiment in the options market. However, implied volatility is moderately high at 59.62, and the IV rank of 21.1 suggests limited potential for a volatility-driven price spike.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
10

Positive Catalysts

  • SwingMax sent an entry signal on 2026-06-09, and the stock has gained 13.88% since then. The options market shows bullish sentiment with a low put-call ratio.

Neutral/Negative Catalysts

  • RSI indicates the stock is overbought. Hedge funds are selling heavily, with a 1606.19% increase in selling activity over the last quarter. Analysts have lowered price targets recently, citing valuation concerns and minor operational issues.

Financial Performance

No financial data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. Barclays lowered its price target to $16 from $19, maintaining an Equal Weight rating. Raymond James lowered its price target to $22 from $27 but kept a Strong Buy rating. UBS raised its price target to $22 from $21 with a Neutral rating. The overall sentiment reflects cautious optimism but highlights valuation concerns.

Wall Street analysts forecast ALHC stock price to rise
9 Analyst Rating
Wall Street analysts forecast ALHC stock price to rise
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 21.420
sliders
Low
18
Averages
21.81
High
30
Current: 21.420
sliders
Low
18
Averages
21.81
High
30
Barclays
Equal Weight
downgrade
$19 -> $16
AI Analysis
2026-05-26
Reason
Barclays
Price Target
$19 -> $16
AI Analysis
2026-05-26
downgrade
Equal Weight
Reason
Barclays lowered the firm's price target on Alignment Healthcare to $16 from $19 and keeps an Equal Weight rating on the shares. The firm believes the managed care stock moves post the Q1 reports are "durable." It continues to prefer managed care over facilities, saying inflation and commercial mix represent increasing drivers of provider earnings risk. Barclays adjusted ratings and targets in the group.
Raymond James
Strong Buy
to
Strong Buy
downgrade
$27 -> $22
2026-05-07
Reason
Raymond James
Price Target
$27 -> $22
2026-05-07
downgrade
Strong Buy
to
Strong Buy
Reason
Raymond James lowered the firm's price target on Alignment Healthcare to $22 from $27 and keeps a Strong Buy rating on the shares. The stock has been under pressure since "a solid quarter" with "some minor hiccups around the hospital payments issue that appear to be contained," says the analyst, who attributes the post-earnings weakness to a "relatively expensive valuation," the fact that Q1 had "some small hiccups," and potentially some rotation into other large cap managed care organizations.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ALHC
Unlock Now

People Also Watch